A blog about chemistry, drug development, science, and technology
M&A activity seems to be picking up recently. Seems AnorMED does not want to be acquired by Genzyme.
I think this sets the stage for a hostile takeover. It rally depends on how much Genzyme wants to spend to acquire AnorMED. Agai, I think Genzyme will up its offer and that AnorMED will accept it.
Here is AnorMED’s pdf on rejecting the offer.
Technorati Tags: Anormed, Genzyme, pharma M&A, pharmaceutical deals
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.002 seconds